insights_auto
Why is KROS down 2.82%?
Dive Deeperchevron_right
KROS:NASDAQ
Keros Therapeutics Inc
$11.04
arrow_downward
-2.82%(-0.32) 1D
Oct 30, 4:00:01āÆPM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KROS...
Open
$11.32
High
$11.49
Low
$10.98
Mkt. cap
218.89M
Avg. vol.
175.87K
Volume
120.16K
52-wk high
$22.55
52-wk low
$9.69
EPS
-$3.70
Beta
1.12
Shares outstanding
19.83M
No. of employees
92
Open
$11.32
High
$11.49
Low
$10.98
Mkt. cap
218.89M
Avg. vol.
175.87K
Volume
120.16K
52-wk high
$22.55
52-wk low
$9.69
EPS
-$3.70
Beta
1.12
Shares outstanding
19.83M
No. of employees
92
News stories
From web sources and news partners
Trefis
·
19 minutes ago
33 S&P 500 Stocks Hit 52-Week Highs On Friday
https://tech-insider.org/
·
1 hour ago
Nasdaq 100 AI Spending Fears: $2T October Wipeout [2026]
The Motley Fool
·
4 hours ago
History Says No 20-Year Stretch in the S&P 500 Has Lost Money Since 1950. Here's What the Worst One Returned.
Investing.com
·
12 hours ago
Okta jumps after-hours following tapped inclusion in the S&P 500
About Keros Therapeutics Inc
CEO-
Employees92
Founded2015
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitekerostx.com